Drawing for CELLEDIT

USPTO serial 87621835

CELLEDIT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
PEREZ, STEVEN M
Law office
TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CELLEDIT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of cancer, infectious disease, immune related disease; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of cancer, infectious disease, immune related disease; Pharmaceutical preparations for cancer, infectious disease, immune related disease; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer, infectious disease, immune related diseaseACTIVEJun 1, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 16, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 16, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 4, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2020CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 27, 2020IUAFUSE AMENDMENT FILED—
Mar 27, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 5, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 3, 2019EX3GSOU EXTENSION 3 GRANTED—
Oct 3, 2019EXT3SOU EXTENSION 3 FILED—
Oct 3, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 5, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 3, 2019EX2GSOU EXTENSION 2 GRANTED—
Apr 3, 2019EXT2SOU EXTENSION 2 FILED—
Apr 3, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 26, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 25, 2018EX1GSOU EXTENSION 1 GRANTED—
Sep 25, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 15, 2018EXT1SOU EXTENSION 1 FILED—
Sep 15, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 15, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 3, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 6, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 6, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 17, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 28, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 28, 2017DOCKASSIGNED TO EXAMINER—
Sep 30, 2017MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 29, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 28, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance